These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
557 related articles for article (PubMed ID: 31031101)
21. Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study. van Vliet EA; Otte WM; Gorter JA; Dijkhuizen RM; Wadman WJ Neurobiol Dis; 2014 Mar; 63():74-84. PubMed ID: 24321435 [TBL] [Abstract][Full Text] [Related]
22. Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion. Edrissi H; Schock SC; Cadonic R; Hakim AM; Thompson CS Brain Res; 2016 Sep; 1646():494-503. PubMed ID: 27350079 [TBL] [Abstract][Full Text] [Related]
23. Blood-Brain Barrier Disruption and Perivascular Spaces in Small Vessel Disease and Neurodegenerative Diseases: A Review on MRI Methods and Insights. Voorter PHM; van Dinther M; Jansen WJ; Postma AA; Staals J; Jansen JFA; van Oostenbrugge RJ; van der Thiel MM; Backes WH J Magn Reson Imaging; 2024 Feb; 59(2):397-411. PubMed ID: 37658640 [TBL] [Abstract][Full Text] [Related]
24. Spatiotemporal Dynamics of Cerebral Vascular Permeability in Type 2 Diabetes-Related Cerebral Microangiopathy. Chen YC; Lu BZ; Shu YC; Sun YT Front Endocrinol (Lausanne); 2021; 12():805637. PubMed ID: 35087478 [TBL] [Abstract][Full Text] [Related]
25. Cerebral Small Vessel Disease. Li Q; Yang Y; Reis C; Tao T; Li W; Li X; Zhang JH Cell Transplant; 2018 Dec; 27(12):1711-1722. PubMed ID: 30251566 [TBL] [Abstract][Full Text] [Related]
26. Sleep as a Novel Biomarker and a Promising Therapeutic Target for Cerebral Small Vessel Disease: A Review Focusing on Alzheimer's Disease and the Blood-Brain Barrier. Semyachkina-Glushkovskaya O; Postnov D; Penzel T; Kurths J Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878058 [TBL] [Abstract][Full Text] [Related]
27. Intravenous infusion of mesenchymal stem cells improves impaired cognitive function in a cerebral small vessel disease model. Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Oka S; Suzuki J; Sasaki Y; Nagahama H; Hashi K; Kocsis JD; Honmou O Neuroscience; 2019 Jun; 408():361-377. PubMed ID: 30999031 [TBL] [Abstract][Full Text] [Related]
30. Subtle blood-brain barrier leakage rate and spatial extent: Considerations for dynamic contrast-enhanced MRI. van de Haar HJ; Jansen JFA; Jeukens CRLPN; Burgmans S; van Buchem MA; Muller M; Hofman PAM; Verhey FRJ; van Osch MJP; Backes WH Med Phys; 2017 Aug; 44(8):4112-4125. PubMed ID: 28493613 [TBL] [Abstract][Full Text] [Related]
31. Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease. Kaiser D; Weise G; Möller K; Scheibe J; Pösel C; Baasch S; Gawlitza M; Lobsien D; Diederich K; Minnerup J; Kranz A; Boltze J; Wagner DC Acta Neuropathol Commun; 2014 Dec; 2():169. PubMed ID: 25519173 [TBL] [Abstract][Full Text] [Related]
32. L-Arginine-eNOS-NO Functional System in Brain Damage and Cognitive Impairments in Cerebral Small Vessel Disease. Dobrynina LA; Shabalina AA; Shamtieva KV; Kremneva EI; Zabitova MR; Krotenkova MV; Burmak AG; Gnedovskaya EV Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37833984 [TBL] [Abstract][Full Text] [Related]
33. Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review. Heye AK; Culling RD; Valdés Hernández Mdel C; Thrippleton MJ; Wardlaw JM Neuroimage Clin; 2014; 6():262-74. PubMed ID: 25379439 [TBL] [Abstract][Full Text] [Related]
34. Advanced MRI in cerebral small vessel disease. van den Brink H; Doubal FN; Duering M Int J Stroke; 2023 Jan; 18(1):28-35. PubMed ID: 35311609 [TBL] [Abstract][Full Text] [Related]
35. Blood-brain barrier permeability and long-term clinical and imaging outcomes in cerebral small vessel disease. Wardlaw JM; Doubal FN; Valdes-Hernandez M; Wang X; Chappell FM; Shuler K; Armitage PA; Carpenter TC; Dennis MS Stroke; 2013 Feb; 44(2):525-7. PubMed ID: 23233386 [TBL] [Abstract][Full Text] [Related]
36. Claudin-1-Dependent Destabilization of the Blood-Brain Barrier in Chronic Stroke. Sladojevic N; Stamatovic SM; Johnson AM; Choi J; Hu A; Dithmer S; Blasig IE; Keep RF; Andjelkovic AV J Neurosci; 2019 Jan; 39(4):743-757. PubMed ID: 30504279 [TBL] [Abstract][Full Text] [Related]
37. MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial. Brown RB; Tozer DJ; Loubière L; Harshfield EL; Hong YT; Fryer TD; Williams GB; Graves MJ; Aigbirhio FI; O'Brien JT; Markus HS Alzheimers Dement; 2024 Jun; 20(6):3852-3863. PubMed ID: 38629936 [TBL] [Abstract][Full Text] [Related]
38. Higher blood-brain barrier permeability is associated with higher white matter hyperintensities burden. Li Y; Li M; Zhang X; Shi Q; Yang S; Fan H; Qin W; Yang L; Yuan J; Jiang T; Hu W J Neurol; 2017 Jul; 264(7):1474-1481. PubMed ID: 28653212 [TBL] [Abstract][Full Text] [Related]
39. Spontaneous white matter lesion in brain of stroke-prone renovascular hypertensive rats: a study from MRI, pathology and behavior. Fan Y; Lan L; Zheng L; Ji X; Lin J; Zeng J; Huang R; Sun J Metab Brain Dis; 2015 Dec; 30(6):1479-86. PubMed ID: 26387009 [TBL] [Abstract][Full Text] [Related]
40. Measuring subtle leakage of the blood-brain barrier in cerebrovascular disease with DCE-MRI: Test-retest reproducibility and its influencing factors. Wong SM; Jansen JFA; Zhang CE; Staals J; Hofman PAM; van Oostenbrugge RJ; Jeukens CRLPN; Backes WH J Magn Reson Imaging; 2017 Jul; 46(1):159-166. PubMed ID: 28160347 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]